KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Return on Equity for 14 consecutive years, with 0.01% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 2.0% year-over-year to 0.01%, compared with a TTM value of 0.01% through Sep 2025, down 2.0%, and an annual FY2024 reading of 0.0%, up 8.0% over the prior year.
  • Return on Equity was 0.01% for Q3 2025 at TherapeuticsMD, up from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 5.35% in Q2 2021 and bottomed at 16.9% in Q4 2022.
  • Average Return on Equity over 5 years is 0.11%, with a median of 0.01% recorded in 2025.
  • The sharpest move saw Return on Equity tumbled -1918bps in 2022, then skyrocketed 1681bps in 2023.
  • Year by year, Return on Equity stood at 2.28% in 2021, then tumbled by -840bps to 16.9% in 2022, then surged by 99bps to 0.09% in 2023, then skyrocketed by 105bps to 0.0% in 2024, then surged by 74bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for TXMD at 0.01% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.